Crown Bioscience Announces San Diego, CA Site Expansion
International Center of Excellence for oncology biomarker and inflammation translational services created
SAN DIEGO, May 09, 2019 (GLOBE NEWSWIRE) -- Crown Bioscience, a global drug discovery and development services company providing translational platforms to advance oncology, inflammation, cardiovascular, and metabolic disease research, today announced the opening of a new facility in San Diego, CA. The new site will become CrownBio’s International Center of Excellence for oncology biomarker and inflammation services.
CrownBio’s presence in San Diego, CA has grown from 17 employees in 2015 to more than 70 today, with additional hiring expected. The custom-designed 32,000 sq. ft. facility provides the additional capacity required to support the growth CrownBio forecasts in its oncology biomarker and inflammation service portfolios. As part of the expansion, significant investment was also made in the latest flow cytometry, radiation and imaging technologies
In the newly created Center of Excellence, CrownBio will enhance its current translational platforms by expanding its existing service portfolio, as well as develop an additional new suite of oncology and inflammation platforms.
The fully-operational facility is designed to ensure a streamlined workflow to optimize study efficiency. Featuring a state-of-the-art ABSL-2 vivarium and laboratory housing an infectious suite and quarantine facilities, the new site hosts significant laboratory space dedicated to storing cryo-preserved cells and tissue, including the world’s largest commercially available collection of patient-derived xenograft (PDX) models.
“The establishment of our International Center of Excellence in San Diego is both an indicator of our continued growth and a commitment to our global and domestic customers,” said CrownBio COO Yangzhou Wang. “The expansion allows us to add to our talented and diverse workforce, which will in turn support the development of novel cancer therapies globally.”
A ribbon cutting ceremony will take place on Tuesday May 14th at 9:30 am PDT
About Crown Bioscience Inc.
Crown Bioscience, a JSR Life Sciences company, is a global drug discovery and development service company providing translational platforms to advance oncology and metabolic disease research. With an extensive portfolio of relevant models and predictive tools, Crown Bioscience enables clients to deliver superior clinical candidates.
For more information visit:
Crown Bioscience Inc.
Information om Globenewswire
Følg pressemeddelelser fra Globenewswire
Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.
Flere pressemeddelelser fra Globenewswire
Biome Grow Inc.24.5.2019 19:10:55 CEST | Pressemeddelelse
Biome Grow Inc. to Announce First Quarter Fiscal 2019 Financial Results.
CGAP24.5.2019 17:06:19 CEST | Pressemeddelelse
Jason Lamb of Gates Foundation Named New Chair of CGAP’s Executive Committee
Collibra23.5.2019 15:01:20 CEST | Pressemeddelelse
Collibra Announces 2019 Excellence Awards Winners
XBiotech Inc.23.5.2019 14:21:06 CEST | Pressemeddelelse
XBiotech Announces Plan to Launch Randomized Phase 2b Study of Bermekimab in Hidradenitis Suppurativa
Merus N.V.23.5.2019 14:02:11 CEST | Pressemeddelelse
Merus Announces 2019 Annual General Meeting of Shareholders
YPO23.5.2019 09:01:35 CEST | Pressemeddelelse
YPO Global Pulse Survey Finds the Customer is Always Right
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.Besøg vores nyhedsrum